1. Home
  2. ORIC vs LAC Comparison

ORIC vs LAC Comparison

Compare ORIC & LAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • LAC
  • Stock Information
  • Founded
  • ORIC 2014
  • LAC 2023
  • Country
  • ORIC United States
  • LAC Canada
  • Employees
  • ORIC N/A
  • LAC N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • LAC Metal Mining
  • Sector
  • ORIC Health Care
  • LAC Basic Materials
  • Exchange
  • ORIC Nasdaq
  • LAC Nasdaq
  • Market Cap
  • ORIC 735.3M
  • LAC 666.1M
  • IPO Year
  • ORIC 2020
  • LAC N/A
  • Fundamental
  • Price
  • ORIC $7.68
  • LAC $2.96
  • Analyst Decision
  • ORIC Strong Buy
  • LAC Hold
  • Analyst Count
  • ORIC 10
  • LAC 8
  • Target Price
  • ORIC $19.13
  • LAC $4.95
  • AVG Volume (30 Days)
  • ORIC 1.6M
  • LAC 4.6M
  • Earning Date
  • ORIC 02-18-2025
  • LAC 11-07-2024
  • Dividend Yield
  • ORIC N/A
  • LAC N/A
  • EPS Growth
  • ORIC N/A
  • LAC N/A
  • EPS
  • ORIC N/A
  • LAC N/A
  • Revenue
  • ORIC N/A
  • LAC N/A
  • Revenue This Year
  • ORIC N/A
  • LAC N/A
  • Revenue Next Year
  • ORIC N/A
  • LAC N/A
  • P/E Ratio
  • ORIC N/A
  • LAC N/A
  • Revenue Growth
  • ORIC N/A
  • LAC N/A
  • 52 Week Low
  • ORIC $6.33
  • LAC $2.02
  • 52 Week High
  • ORIC $16.65
  • LAC $7.71
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 36.65
  • LAC 43.56
  • Support Level
  • ORIC $7.34
  • LAC $2.96
  • Resistance Level
  • ORIC $14.67
  • LAC $3.13
  • Average True Range (ATR)
  • ORIC 1.56
  • LAC 0.13
  • MACD
  • ORIC -0.45
  • LAC 0.01
  • Stochastic Oscillator
  • ORIC 4.64
  • LAC 36.59

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.

About LAC Lithium Americas Corp.

Lithium Americas is a pure-play lithium producer. The firm owns 62% of one resource, Thacker Pass, that is located in northwest Nevada, with automaker General Motors owning the remaining 38%. Thacker Pass recently began construction and is expected to begin production in the mid- to late 2020s. Thacker Pass is one of the largest known lithium resources in the world. The project would be the first clay-based asset to enter production, and we estimate it will be in bottom half of the global cost curve. Management plans to develop Thacker Pass into a fully integrated lithium production site, with downstream refining capabilities on site, and will sell into the lithium chemical market.

Share on Social Networks: